Open access

Research article

First published online March, 2021

Dual Inhibition by Phosphodiesterase 5 and 5-HT2B Inhibitor Leads to Near Complete Amelioration of Fibrotic Potential of Human Adult Dermal Fibroblasts Isolated from a Scleroderma Patient